GTN:FRA
Getinge publ AB
€19.38
arrow_upward
+3.55%(+0.67) 1D
Jul 17, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GTN...
Open
€19.06
High
€19.38
Low
€19.06
Mkt. cap
59.09B
Avg. vol.
38.00
Volume
300.00
52-wk high
€21.11
52-wk low
€16.36
No. of employees
12K
Open
€19.06
High
€19.38
Low
€19.06
Mkt. cap
59.09B
Avg. vol.
38.00
Volume
300.00
52-wk high
€21.11
52-wk low
€16.36
No. of employees
12K
News stories
From sources across the web
ad-hoc-news.de
·
12 hours ago
Getinge B stock holds steady as 2025 sales reached SEK 33.9 billion
The Globe and Mail
·
16 hours ago
Getinge AB Earnings Call Signals Margin Momentum
Investing.com
·
2 days ago
Earnings call transcript: Getinge rises on Q2 2026 margin gains and growth
Seeking Alpha
·
2 days ago
Getinge AB (publ) 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:GNGBY) 2026-07-17
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB
AI content may include mistakes. Learn more